Provided by Tiger Trade Technology Pte. Ltd.

GH Research PLC

22.86
-0.6200-2.64%
Post-market: 22.860.00000.00%19:30 EDT
Volume:255.12K
Turnover:5.84M
Market Cap:1.57B
PE:-23.19
High:23.90
Open:23.31
Low:22.53
Close:23.48
52wk High:31.44
52wk Low:12.04
Shares:68.56M
Float Shares:32.37M
Volume Ratio:0.47
T/O Rate:0.79%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9857
EPS(LYR):-0.7900
ROE:-18.79%
ROA:-13.02%
PB:4.36
PE(LYR):-28.94

Loading ...

GH Research says Phase 2a trial shows inhaled GH001 drives rapid remission in postpartum depression patients

Reuters
·
Jun 04

GH Research says Phase 2b trial shows GH001 cuts anhedonia scores in TRD

Reuters
·
May 21

Stock Track | GH Research PLC Soars 5.19% in Pre-market on Positive Phase 2b Data and New Financing Tools

Stock Track
·
May 18

Phase 2b JAMA Data and New Financing Tools Could Be A Game Changer For GH Research (GHRS)

Simply Wall St.
·
May 18

Analysts Offer Insights on Healthcare Companies: Oruka Therapeutics (ORKA), GH Research (GHRS) and Doximity (DOCS)

TIPRANKS
·
May 16

These Analysts Revise Their Forecasts On GH Research After Q1 Results

Benzinga Earnings
·
May 15

Canaccord Genuity Keeps Their Buy Rating on GH Research (GHRS)

TIPRANKS
·
May 15

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
May 15

GH Research files $400M mixed securities shelf

TIPRANKS
·
May 14

BRIEF-GH Research PLC - May Offer Up To $400 Million In Securities - SEC Filing

Reuters
·
May 14

GH Research Plc - May Offer up to $400 Mln in Securities - SEC Filing

THOMSON REUTERS
·
May 14

GH Research Plc - May Offer and Sell up to $200 Mln of Ordinary Shares - SEC Filing

THOMSON REUTERS
·
May 14

GH Research Plc - Enters at-the-Market Equity Offering Sales Agreement With Stifel - SEC Filing

THOMSON REUTERS
·
May 14

GH Research Q1 net loss widens to $18.97 million

Reuters
·
May 14

Earnings Flash (GHRS) GH Research Posts Q1 Loss $0.31 a Share, vs. FactSet Est of $0.29 Loss

MT Newswires Live
·
May 14

Ireland's GH Research Q1 net loss widens on higher expenses

Reuters
·
May 14

GH Research publishes corporate presentation on GH001 inhaled mebufotenin for treatment-resistant depression

Reuters
·
May 14

GH Research Plc Q1 EPS USD -0.31

THOMSON REUTERS
·
May 14

GH Research Plc: Are Seeking FDA Alignment on Global Phase 3 Pivotal Program, Continue to Target Initiation of Global Pivotal Program in Late 2026

THOMSON REUTERS
·
May 14

GH Research announces annual shareholder meeting notice

Reuters
·
May 14